Dataset Information

Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI.

ABSTRACT: Evaluation of nonenhancing tumor (NET) burden is an important yet challenging part of brain tumor response assessment. This study focuses on using dual-echo turbo spin-echo MRI as a means of quickly estimating tissue T2, which can be used to objectively define NET burden.A series of experiments were performed to establish the use of T2 maps for defining NET burden. First, variation in T2 was determined using the American College of Radiology (ACR) water phantoms in 16 scanners evaluated over 3 years. Next, the sensitivity and specificity of T2 maps for delineating NET from other tissues were examined. Then, T2-defined NET was used to predict survival in separate subsets of patients with glioblastoma treated with radiotherapy, concurrent radiation, and chemotherapy, or bevacizumab at recurrence.Variability in T2 in the ACR phantom was 3% to 5%. In training data, ROC analysis suggested that 125 ms < T2 < 250 ms could delineate NET with a sensitivity of >90% and specificity of >65%. Using this criterion, NET burden after completion of radiotherapy alone, or concurrent radiotherapy, and chemotherapy was shown to be predictive of survival (Cox, P < 0.05), and the change in NET volume before and after bevacizumab therapy in recurrent glioblastoma was also a predictive of survival (P < 0.05).T2 maps using dual-echo data are feasible, stable, and can be used to objectively define NET burden for use in brain tumor characterization, prognosis, and response assessment. The use of effective T2 maps for defining NET burden should be validated in a randomized, clinical trial.

SUBMITTER: Ellingson BM

PROVIDER: S-EPMC4592379 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI.

Ellingson Benjamin M BM Lai Albert A Nguyen Huytram N HN Nghiemphu Phioanh L PL Pope Whitney B WB Cloughesy Timothy F TF

Clinical cancer research : an official journal of the American Association for Cancer Research 20150421 19

<h4>Purpose</h4>Evaluation of nonenhancing tumor (NET) burden is an important yet challenging part of brain tumor response assessment. This study focuses on using dual-echo turbo spin-echo MRI as a means of quickly estimating tissue T2, which can be used to objectively define NET burden.<h4>Experimental design</h4>A series of experiments were performed to establish the use of T2 maps for defining NET burden. First, variation in T2 was determined using the American College of Radiology (ACR) wate ...[more]

PMID: 25901082

Similar Datasets

Project description:Background/Aim: The turbo spin-echo (TSE) sequence is widely used for musculoskeletal (MSK) imaging; however, its acquisition speed is limited and can be easily affected by motion artifacts. We aimed to evaluate whether the use of a simultaneous multi-slice TSE (SMS-TSE) sequence can accelerate MSK imaging while maintaining image quality when compared with the routine TSE sequence. Methods: We prospectively enrolled 71 patients [mean age, 37.43 ± 12.56 (range, 20-67) years], including 37 men and 34 women, to undergo TSE and SMS sequences. The total scanning times for the wrist, ankle and knee joint with routine sequence were 14.92, 13.97, and 13.48 min, respectively. For the SMS-TSE sequence, they were 7.52, 7.20, and 6.87 min. Quantitative parameters, including the signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR), were measured. Three experienced MSK imaging radiologists qualitatively evaluated the image quality of bone texture, cartilage, tendons, ligament, meniscus, and artifact using a 5-point evaluation system, and the diagnostic performance of the SMS-TSE sequences was evaluated. Results: Compared with the routine TSE sequences, the scanning time was lower by 49.60, 48.46, and 49.04% using SMS-TSE sequences for the wrist, ankle, and knee joints, respectively. For the SNR comparison, the SMS-TSE sequences were significantly higher than the routine TSE sequence for wrist (except for Axial-T2WI-FS), ankle, and knee joint MR imaging (all p < 0.05), but no statistical significance was obtained for the CNR measurement (all p > 0.05, except for Sag-PDWI-FS in ankle joint). For the wrist joint, the diagnostic sensitivity, specificity, and accuracy were 88.24, 100, and 92%. For the ankle joint, they were 100, 75, and 93.33%. For the knee joint, they were 87.50, 85.71, and 87.10%. Conclusion: The use of the SMS-TSE sequence in the wrist, ankle, and knee joints can significantly reduce the scanning time and show similar image quality when compared with the routine TSE sequence.

Project description:ObjectiveTo determine the feasibility and biologic correlations of dynamic susceptibility contrast (DSC), dynamic contrast enhanced (DCE), and quantitative maps derived from contrast leakage effects obtained simultaneously in gliomas using dynamic spin-and-gradient-echo echoplanar imaging (dynamic SAGE-EPI) during a single contrast injection.Materials and methodsThirty-eight patients with enhancing brain gliomas were prospectively imaged with dynamic SAGE-EPI, which was processed to compute traditional DSC metrics (normalized relative cerebral blood flow [nrCBV], percentage of signal recovery [PSR]), DCE metrics (volume transfer constant [Ktrans], extravascular compartment [ve]), and leakage effect metrics: ΔR2,ss* (reflecting T2*-leakage effects), ΔR1,ss (reflecting T1-leakage effects), and the transverse relaxivity at tracer equilibrium (TRATE, reflecting the balance between ΔR2,ss* and ΔR1,ss). These metrics were compared between patient subgroups (treatment-naïve [TN] vs recurrent [R]) and biological features (IDH status, Ki67 expression).ResultsIn IDH wild-type gliomas (IDHwt-i.e., glioblastomas), previous exposure to treatment determined lower TRATE (p = 0.002), as well as higher PSR (p = 0.006), Ktrans (p = 0.17), ΔR1,ss (p = 0.035), ve (p = 0.006), and ADC (p = 0.016). In IDH-mutant gliomas (IDHm), previous treatment determined higher Ktrans and ΔR1,ss (p = 0.026). In TN-gliomas, dynamic SAGE-EPI metrics tended to be influenced by IDH status (p ranging 0.09-0.14). TRATE values above 142 mM-1s-1 were exclusively seen in TN-IDHwt, and, in TN-gliomas, this cutoff had 89% sensitivity and 80% specificity as a predictor of Ki67 > 10%.ConclusionsDynamic SAGE-EPI enables simultaneous quantification of brain tumor perfusion and permeability, as well as mapping of novel metrics related to cytoarchitecture (TRATE) and blood-brain barrier disruption (ΔR1,ss), with a single contrast injection.Clinical relevance statementSimultaneous DSC and DCE analysis with dynamic SAGE-EPI reduces scanning time and contrast dose, respectively alleviating concerns about imaging protocol length and gadolinium adverse effects and accumulation, while providing novel leakage effect metrics reflecting blood-brain barrier disruption and tumor tissue cytoarchitecture.Key points• Traditionally, perfusion and permeability imaging for brain tumors requires two separate contrast injections and acquisitions. • Dynamic spin-and-gradient-echo echoplanar imaging enables simultaneous perfusion and permeability imaging. • Dynamic spin-and-gradient-echo echoplanar imaging provides new image contrasts reflecting blood-brain barrier disruption and cytoarchitecture characteristics.

Dataset Information

Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI.

Publications

Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets